StonvexLoading…
StonvexStonvexStonvexCore line items from KBR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Annual 2026 2026-01-02 | Q4 2025 2025-10-03 | Q3 2025 2025-07-04 |
|---|---|---|---|---|
Revenue | $1.92B | $7.79B | $5.90B | $3.97B |
Operating Income | $180.00M | $778.00M | $587.00M | $396.00M |
Net Income | $102.00M | $415.00M | $304.00M | $189.00M |
EPS (Diluted) | $0.80 | $3.21 | $2.33 | $1.44 |
Total Assets | $6.63B | $6.58B | $6.65B | $6.79B |
Total Liabilities | $5.04B | $5.07B | $5.18B | $5.30B |
Cash & Equivalents | $380.00M | $500.00M | $539.00M | $403.00M |
Free Cash Flow OCF − CapEx | $98.00M | $515.00M | $482.00M | $292.00M |
Shares Outstanding | 126.79M | 126.45M | 126.99M | 128.84M |